medigraphic.com
ISSN 2007-6053 (Print)
Órgano oficial de difusión de los Hospitales Regionales de Alta Especialidad (HRAE)

2015, Number 2

<< Back Next >>

Evid Med Invest Salud 2015; 8 (2)

Nose lymphoma of T/NK cells

Gutiérrez-Alvarado RA, Hernández-González D, Gil-Enriquez D, Pacheco UF, Williams D

Language: Spanish
References: 14
Page: 89-92
PDF size: 379.20 Kb.


ABSTRACT

Nose T cell and natural killer cell lymphoma (T/NK), having been given many names, is known today as extranodal T/NK cell lymphoma, nasal type. We present a case of a 43 years old man, fisherman, with acquired immunodeficiency syndrome (AIDS). He began ailment with holocraneal headache, right facial palsy, ptosis, amaurosis and blubbery vision. Computed tomography and magnetic resonance were performed stablishing diagnosed tumor of paranasal sinus compatible with lymphoma. He is taken to surgery for excisional biopsy.


REFERENCES

  1. Borges A, Fink J, Villablanca P et al. Midline destructive lesions of the sinonasal tract: simplified terminology based on histopathologic criteria. AJNR Am J Neuroradiol. 2000; 21: 331-336.

  2. Jakic-Razumovic J, Aurer I. The World Health Organization classification of lymphomas. Creat Med J. 2002; 43: 527-534.

  3. Jaffe ES, Chan JK, Su IJ et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Am J Surg Pathol. 1996; 20: 103-111.

  4. Jaffe S E. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood. 1996; 87: 1207-1210.

  5. Torre-Iturraspe A, Llorente-Pendás S et al. Linfoma nasal de células T/NK. Rev Esp Cir Oral y Maxilofac. 2005; 27: 2100-2108.

  6. Meneses-García A, Súchil-Bernal L, de la Garza-Salazar J, Gómez-González E. Linfomas anagiocéntricos centrofaciales de células T/NK. Aspectos histológicos y algunas consideraciones clínicas de 30 pacientes del Instituto Nacional de Cancerología, México. Cir Ciruj. 2002; 70: 410-416.

  7. Globocan 2008. Disponible en: http://www-dep.iarc.fr/

  8. Labardini et al. Linfoma no Hodgkin. Cancerología. 2011; 6: 139-152.

  9. Carballo VA, Martínez-Alvarado L, Sturich G, García JC, Diller A, Zlocowski JC et al. Comportamiento del linfoma sistémico en pacientes con VIH/SIDA. Revisión de casos. Experiencia Médica. 2011; 29 (1): 28-33.

  10. Mocroft A, Katlama C, Jonhson A et al. AIDS across Europe 1994-98: The EuroSIDA study. Lancet. 2000; 356: 291-296.

  11. Corti M, Soler M, Bare P et al. Linfomas asociados con la infección por el virus de la inmunodeficiencia humana: subtipos histológicos y asociación con los virus de Epstein Barr y Herpes-8. Medicina (Buenos Aires). 2010; 70: 151-158.

  12. Thorley-Lawson DA, Gross A. Persistence of the Epstein Barr virus and the origin of associated lymphomas. N Engl J Med. 2004; 350 (13): 1328-1337.

  13. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus infected adults. J Nat Cancer. 2000; 92 (22): 1823-1830. Citado por el Instituto Nacional del Cáncer en su página web.

  14. Stebbing J, Gazzard B, Mandalia S. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non Hodgkin lymphoma. J Clin Oncol. 2004; 22 (11): 2177-2183.




2020     |     www.medigraphic.com